European Commission Approves Novavax's Adapted COVID-19 Vaccine for Winter Season

The European Commission has granted approval for the Nuvaxovid XBB.1.5-adapted COVID-19 vaccine, a groundbreaking step in the fight against the ever-evolving pandemic. Developed by Novavax, this marks the first protein-based vaccine tailored to address the unique challenges posed by the autumn-winter season.

New COVID variant not detected in Türkiye, minister says

Health Minister Fahrettin Koca has announced that the country has not detected the presence of the new variant of COVID-19, EG.5, within its borders.

"Do not worry about these variants. There is no such thing as a transition to the periods that we have closed," Koca declared in a press address held in the Central Anatolian province of Kırşehir on Aug. 23.